160.32MMarket Cap
LossP/E TTM
Tenaya Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-08-14The current valuation score of Tenaya Therapeutics Inc is 6.09, ranking 373 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.67, which is -79.89% below the recent high of -0.34 and -142.47% above the recent low of -4.04.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.